Literature DB >> 19127381

Early indicators of treatment success after percutaneous radiofrequency of pulmonary tumors.

Ewan Mark Anderson1, W R Lees, A R Gillams.   

Abstract

We retrospectively reviewed the imaging of patients after radiofrequency ablation (RFA) of lung metastases performed at our institution to assess the usefulness of ground glass opacification (GGO) margin for the prediction of complete tumor ablation. From January 2004 to March 2007, patients were identified where there was a postprocedure thin collimation scan to allow multiplanar reformatting, either immediately or at 24 h and at least 6 months of imaging follow-up. Thirty-six tumors in 22 patients were identified. The scans were assessed for the presence and width of GGO margin, and minimal and maximal dimensions were measured. A second reviewer, blinded to the outcome of the postprocedure assessment, reviewed the follow-up imaging for recurrence. The recurrence group had larger tumors (p = 0.045) and smaller mean minimal GGO margin width (p = 0.0001). Multivariate binary regression analysis confirmed that the minimal GGO margin was significantly (p < 0.005) associated with tumor recurrence. Receiver operator characteristic curve analysis suggests a cutoff of 4.5 mm for complete tumor ablation. There was substantial agreement (kappa = 0.759) between the site of absent GGO margin and the site of tumor recurrence. The point on the tumor surface where there is no GGO margin is likely to be the site of future recurrence. In our experience, a circumferential GGO margin of >5 mm is the minimal margion required to ensure complete tumor ablation.

Entities:  

Mesh:

Year:  2009        PMID: 19127381     DOI: 10.1007/s00270-008-9482-6

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  34 in total

1.  Micropapillary and/or Solid Histologic Subtype Based on Pre-Treatment Biopsy Predicts Local Recurrence After Thermal Ablation of Lung Adenocarcinoma.

Authors:  Song Gao; Seth Stein; Elena N Petre; Waleed Shady; Jeremy C Durack; Carole Ridge; Prasad Adusumilli; Natasha Rekhtman; Stephen B Solomon; Etay Ziv
Journal:  Cardiovasc Intervent Radiol       Date:  2017-08-02       Impact factor: 2.740

2.  Loss of cellular viability in areas of ground-glass opacity on computed tomography images immediately after pulmonary radiofrequency ablation in rabbits.

Authors:  Masaomi Kuroki; Hiroshi Nakada; Atsushi Yamashita; Akira Sawaguchi; Noriko Uchino; Shinya Sato; Taketoshi Asanuma; Yujiro Asada; Shozo Tamura
Journal:  Jpn J Radiol       Date:  2012-05       Impact factor: 2.374

3.  A comparison between 915 MHz and 2450 MHz microwave ablation systems for the treatment of small diameter lung metastases.

Authors:  Thomas J Vogl; Andrei Roman; Nour-Eldin A Nour-Eldin; Wolfgang Hohenforst-Schmidt; Iliana Bednarova; Benjamin Kaltenbach
Journal:  Diagn Interv Radiol       Date:  2018 Jan-Feb       Impact factor: 2.630

Review 4.  The role of percutaneous image-guided ablation for lung tumors.

Authors:  Elena N Petre; Stephen B Solomon; Constantinos T Sofocleous
Journal:  Radiol Med       Date:  2014-07-01       Impact factor: 3.469

Review 5.  Lung radiofrequency and microwave ablation: a review of indications, techniques and post-procedural imaging appearances.

Authors:  S L Smith; P E Jennings
Journal:  Br J Radiol       Date:  2014-12-03       Impact factor: 3.039

Review 6.  Alternative to surgery in early stage NSCLC-interventional radiologic approaches.

Authors:  Kyungmouk Steve Lee; Bradley B Pua
Journal:  Transl Lung Cancer Res       Date:  2013-10

Review 7.  Lung cancer ablation: what is the evidence?

Authors:  Thierry de Baere; Geoffroy Farouil; Frederic Deschamps
Journal:  Semin Intervent Radiol       Date:  2013-06       Impact factor: 1.513

Review 8.  Imaging Features following Thermal Ablation of Lung Malignancies.

Authors:  Sophie Chheang; Feredoin Abtin; Antonio Guteirrez; Scott Genshaft; Robert Suh
Journal:  Semin Intervent Radiol       Date:  2013-06       Impact factor: 1.513

9.  Lung Adenocarcinoma: Predictive Value of KRAS Mutation Status in Assessing Local Recurrence in Patients Undergoing Image-guided Ablation.

Authors:  Etay Ziv; Joseph P Erinjeri; Hooman Yarmohammadi; F Edward Boas; Elena N Petre; Song Gao; Waleed Shady; Constantinos T Sofocleous; David R Jones; Charles M Rudin; Stephen B Solomon
Journal:  Radiology       Date:  2016-07-19       Impact factor: 11.105

Review 10.  Tumour ablation: current role in the kidney, lung and bone.

Authors:  Alice Gillams
Journal:  Cancer Imaging       Date:  2009-10-02       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.